Santhera Pharmaceuticals Holding AG
SIX:SANN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Santhera Pharmaceuticals Holding AG
SIX:SANN
|
CH |
|
E
|
Enel SpA
DUS:ENL
|
IT |
|
F
|
Fabasoft AG
DUS:FAA
|
AT |
|
A
|
Ageas SA
F:FO4N
|
BE |
|
A
|
American Electric Power Company Inc
SWB:AEP
|
US |
|
A
|
AP Moeller - Maersk A/S
DUS:DP4B
|
DK |
|
Northern Superior Resources Inc
XTSX:SUP
|
CA |
|
A
|
AP Moeller - Maersk A/S
XMUN:DP4B
|
DK |
|
Sartorius Stedim Biotech SA
F:56S0
|
FR |
|
Eclipx Group Ltd
ASX:ECX
|
AU |
|
Husqvarna AB
LSE:0GTR
|
SE |
|
Gunnison Copper Corp
F:3XS0
|
US |
|
V
|
Viscofan SA
XBER:VIS
|
ES |
|
C
|
Canadian Tire Corporation Ltd
OTC:CDNAF
|
CA |
|
M
|
Mazda Motor Corp
XMUN:MZA
|
JP |
|
Komercni Banka as
F:KONN
|
CZ |
|
Moneysupermarket.Com Group PLC
LSE:MONY
|
UK |
Wall St Price Targets
SANN Price Targets Summary
Santhera Pharmaceuticals Holding AG
According to Wall Street analysts, the average 1-year price target for SANN is 28.05 CHF with a low forecast of 25.25 CHF and a high forecast of 31.5 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SANN's stock price target?
Price Target
28.05
CHF
According to Wall Street analysts, the average 1-year price target for SANN is 28.05 CHF with a low forecast of 25.25 CHF and a high forecast of 31.5 CHF.
What is the Revenue forecast for Santhera Pharmaceuticals Holding AG?
Projected CAGR
49%
Over the last 13 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 3 years is 49%.
What is the Gross Profit forecast for Santhera Pharmaceuticals Holding AG?
Projected CAGR
-19%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 4 years is -19%.
